You are here

Vivace Therapeutics

AACR 2023 – Hippo makes a splash

EP Vantage

Wed, 04/19/23 - 10:07 am

Vivace Therapeutics

AACR 2023 – Moderna's immunotherapeutic splash

EP Vantage

Wed, 03/22/23 - 10:03 am

Moderna Therapeutics

Relay Therapeutics

Vivace Therapeutics

Vivace Therapeutics scores $30M Series C to take oncology candidate for 'Hippo' pathway to human trial next year

Endpoints

Wed, 12/16/20 - 12:38 pm

Vivace Therapeutics

Vivace Therapeutics Comes Out of Stealth With $25M for Cancer Drugs

Xconomy

Wed, 06/28/17 - 09:50 am

Vivace Therapeutics